Evaluation Of the Protective Effects of Coenzyme Q10, Vitamin E, And Their Combination Against Simvastatin-Induced Myopathy in Male Rats (An Immunohistochemistry Study)
DOI:
https://doi.org/10.32947/ajps.v25i5.1287Keywords:
simvastatin, CoQ10, vitamin E, BAX, myopathy, immunohistochemistryAbstract
One of the significant adverse effects of statin medication is simvastatin-induced myopathy, for which there are few effective preventative measures. Simvastatin-induced skeletal muscle myopathy in male rats was assessed in this study utilizing immunohistochemical analysis of BAX (BCL2-associated protein X) expression to determine the preventive effects of Coenzyme Q10, Vitamin E, and their combination.
After being divided into groups, the rats were given simvastatin, Coenzyme Q10, vitamin E, or all three together for 30 days. The treatment groups' levels of BAX expression, a marker of apoptosis, were considerably lower than those of the group taking simvastatin alone. The biggest reduction was seen with the combination treatment, with an average immunohistochemistry (IHC) -intensity score of 1.0 ± 0.577, whereas the induction group's score was 2.857 ± 0.378. These results demonstrated the ability of vitamin E and Coenzyme Q10, particularly when combined, to reduce statin-induced muscle apoptosis. Future suggested treatment approaches to stop myopathy in statin users are based on the findings.
References
1- Castro C, Gourley M. Diagnosis and treatment of inflammatory myopathy: issues and management. Ther Adv Musculoskelet Dis. 2012;4(2):111-20.
2- Frontera WR, Ochala J. Skeletal Muscle: A Brief Review of Structure and Function. Calcified Tissue International. 2015;96(3):183-95.
3- Alonso R, Cuevas A, Cafferata A. Diagnosis and management of statin intolerance. Journal of atherosclerosis and thrombosis. 2019;26(3):207-15.
4- Talreja O, Kerndt CC, Cassagnol M. Simvastatin. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC.; 2024.
5- Aronson D. Simvastatin. In: Aronson JK, editor. Meyler's Side Effects of Drugs (Sixteenth Edition). Oxford: Elsevier; 2016. p. 389-95.
6- Mullen PJ, Lüscher B, Scharnagl H, Krähenbühl S, Brecht K. Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy. Biochemical Pharmacology. 2010;79(8):1200-9.
7- Morita I, Sato I, Ma L, Murota S-I. Enhancement of Membrane Fluidity in Cholesterol-Poor Endothelial Cells Pre-treated with Simvastatin. Endothelium. 1997;5(2):107-13.
8- Sanvee GM, Panajatovic MV, Bouitbir J, Krähenbühl S. Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle. Biochemical pharmacology. 2019;164:23-33.
9- Nunnari J, Suomalainen A. Mitochondria: In Sickness and in Health. Cell. 2012;148(6):1145-59.
10- Dahri M, Tarighat-Esfanjani A, Asghari-Jafarabadi M, Hashemilar M. Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers. Nutr Neurosci. 2019;22(9):607-15.
11- Du J, Wang T, Huang P, Cui S, Gao C, Lin Y, et al. Clinical correlates of decreased plasma coenzyme Q10 levels in patients with multiple system atrophy. Parkinsonism Relat Disord. 2018;57:58-62.
12- Bentinger M, Tekle M, Dallner G. Coenzyme Q – Biosynthesis and functions. Biochemical and Biophysical Research Communications. 2010;396(1):74-9.
13- Molyneux SL, Young JM, Florkowski CM, Lever M, George PM. Coenzyme Q10: is there a clinical role and a case for measurement? Clin Biochem Rev. 2008;29(2):71-82.
14- Skarlovnik A, Janić M, Lunder M, Turk M, Šabovič M. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med Sci Monit. 2014;20:2183-8.
15- Sabliov CM, Astete CE. 12 - Encapsulation and controlled release of antioxidants and vitamins. In: Garti N, editor. Delivery and Controlled Release of Bioactives in Foods and Nutraceuticals: Woodhead Publishing; 2008. p. 297-330.
16- Rizvi S, Raza ST, Ahmed F, Ahmad A, Abbas S, Mahdi F. The role of vitamin e in human health and some diseases. Sultan Qaboos Univ Med J. 2014;14(2):e157-65.
17- Arca M, Natoli S, Micheletta F, Riggi S, Di Angelantonio E, Montali A, et al. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy. Free Radic Biol Med. 2007;42(5):698-705.
18- Diepeveen SH, Verhoeven GW, Van Der Palen J, Dikkeschei LD, Van Tits LJ, Kolsters G, et al. Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial. J Intern Med. 2005;257(5):438-45.
19- Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Rönnemaa T. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. Jama. 2002;287(5):598-605.
20- Shin MJ, Chung N, Lee JH, Jang Y, Park E, Jeon KI, et al. Effects of simvastatin on plasma antioxidant status and vitamins in hypercholesterolemic patients. Int J Cardiol. 2007;118(2):173-7.
21- Cangemi R, Loffredo L, Carnevale R, Pignatelli P, Violi F. Statins enhance circulating vitamin E. Int J Cardiol. 2008;123(2):172-4.
22- Tousoulis D, Antoniades C, Vassiliadou C, Toutouza M, Pitsavos C, Tentolouris C, et al. Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure. Eur J Heart Fail. 2005;7(7):1126-32.
23- Mykkänen AJH, Taskinen S, Neuvonen M, Paile-Hyvärinen M, Tarkiainen EK, Lilius T, et al. Genomewide Association Study of Simvastatin Pharmacokinetics. Clin Pharmacol Ther. 2022;112(3):676-86.
24- Mahmoud AR, Kamel EO, Ahmed MA, Ahmed EA, Abd-Elhamid TH. Alleviation of Simvastatin-Induced Myopathy in Rats by the Standardized Extract of Ginkgo Biloba (EGb761): Insights into the Mechanisms of Action. Cells Tissues Organs. 2019;208(3-4):158-76.
25- Khalil MS, Khamis N, Al-Drees A, Abdulghani HM. Does coenzyme-Q have a protective effect against atorvastatin induced myopathy? A histopathological and immunohistochemical study in albino rats. Histol Histopathol. 2015;30(3):383-90.
26- Harandi VM, Oliveira BMS, Allamand V, Friberg A, Fontes-Oliveira CC, Durbeej M. Antioxidants Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy. Antioxidants (Basel). 2020;9(3).
27- Struck MB, Andrutis KA, Ramirez HE, Battles AH. Effect of a short-term fast on ketamine-xylazine anesthesia in rats. J Am Assoc Lab Anim Sci. 2011;50(3):344-8.
28- Areloegbe SE, Chukwubueze AL, Oyabambi AO, Olaniyi KS. Low-dose spironolactone attenuates metabolic defects in the skeletal muscle of letrozole-induced hyperandrogenic female rats. Nutrire. 2023;48(1):20.
29- Metindir J, Dilek GB, Pak I. Staining characterization by immunohistochemistry of tumor cancer antigen in patients with endometrial cancer. Eur J Gynaecol Oncol. 2008;29(5):489-92.
30- Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior research methods. 2007;39(2):175-91.
31- Charan J, Kantharia ND. How to calculate sample size in animal studies? Journal of pharmacology & pharmacotherapeutics. 2013;4(4):303-6.
32- Festing MFW. Design and Statistical Methods in Studies Using Animal Models of Development. ILAR J. 2006;47(1):5-14.
33- Kane M. Simvastatin Therapy and SLCO1B1 Genotype. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries. Bethesda (MD): National Center for Biotechnology Information (US); 2012.
34- Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020;159:4-33.
35- Fairley LH, Das S, Dharwal V, Amorim N, Hegarty KJ, Wadhwa R, et al. Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease. Antioxidants. 2023;12(4):973.
36- Bagheri S, Haddadi R, Saki S, Kourosh-Arami M, Rashno M, Mojaver A, et al. Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article. Frontiers in Neuroscience. 2023;17.
37- da Cunha Germano BC, de Morais LCC, Idalina Neta F, Fernandes ACL, Pinheiro FI, do Rego ACM, et al. Vitamin E and Its Molecular Effects in Experimental Models of Neurodegenerative Diseases. Int J Mol Sci. 2023;24(13).
38- Wang XL, Rainwater DL, Mahaney MC, Stocker R. Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons. Am J Clin Nutr. 2004;80(3):649-55.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Omar Ammar Hashim, Intesar Tarik Numan, Nadia Hameed Mohammed, Mohammed Abdaljabar Abdalqader
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
